Daré Bioscience Statistics Share Statistics Daré Bioscience has 8.85M
shares outstanding. The number of shares has increased by 3.56%
in one year.
Shares Outstanding 8.85M Shares Change (YoY) 3.56% Shares Change (QoQ) 1.72% Owned by Institutions (%) 9.73% Shares Floating 8.71M Failed to Deliver (FTD) Shares 338,758 FTD / Avg. Volume 22.13%
Short Selling Information The latest short interest is 1.11M, so 12.53% of the outstanding
shares have been sold short.
Short Interest 1.11M Short % of Shares Out 12.53% Short % of Float 12.67% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -6.54 and the forward
PE ratio is -1.52.
Daré Bioscience's PEG ratio is
0.07.
PE Ratio -6.54 Forward PE -1.52 PS Ratio 2709.59 Forward PS 0.7 PB Ratio 0 P/FCF Ratio 5.5 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Daré Bioscience.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.85,
with a Debt / Equity ratio of 0.
Current Ratio 0.85 Quick Ratio 0.85 Debt / Equity 0 Debt / EBITDA -0.06 Debt / FCF 0.27 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $465.9 Profits Per Employee $-193.05K Employee Count 21 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -43.71% in the
last 52 weeks. The beta is 1.11, so Daré Bioscience's
price volatility has been higher than the market average.
Beta 1.11 52-Week Price Change -43.71% 50-Day Moving Average 2.67 200-Day Moving Average 3.06 Relative Strength Index (RSI) 26.89 Average Volume (20 Days) 1,530,458
Income Statement In the last 12 months, Daré Bioscience had revenue of 9.78K
and earned -4.05M
in profits. Earnings per share was -0.48.
Revenue 9.78K Gross Profit -14.29M Operating Income -23.45M Net Income -4.05M EBITDA -23.41M EBIT -23.45M Earnings Per Share (EPS) -0.48
Full Income Statement Balance Sheet The company has 15.7M in cash and 1.3M in
debt, giving a net cash position of 14.4M.
Cash & Cash Equivalents 15.7M Total Debt 1.3M Net Cash 14.4M Retained Earnings -175.29B Total Assets 18.62M Working Capital -9.37M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 5.39M
and capital expenditures -573.05K, giving a free cash flow of 4.82M.
Operating Cash Flow 5.39M Capital Expenditures -573.05K Free Cash Flow 4.82M FCF Per Share 0.57
Full Cash Flow Statement Margins Gross margin is -146105.89%, with operating and profit margins of -239687.24% and -41435%.
Gross Margin -146105.89% Operating Margin -239687.24% Pretax Margin -41435% Profit Margin -41435% EBITDA Margin -239257.97% EBIT Margin -239687.24% FCF Margin 49276.38%
Dividends & Yields DARE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for DARE is $12.5,
which is 534.5% higher than the current price. The consensus rating is "Buy".
Price Target $12.5 Price Target Difference 534.5% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 1, 2024. It was a
backward
split with a ratio of 1:12.
Last Split Date Jul 1, 2024 Split Type backward Split Ratio 1:12
Scores Altman Z-Score -17.63 Piotroski F-Score 1
